Compare
Two peptides, one row at a time.
Pick any two indexed peptides. The URL captures your selection - paste it in a deck, an email, a paper. The view stays the same for any reader who opens it.
Peptide A
AOD-9604 (hGH 176-191)
warningBioGate · AMBERGrade B
lipolysis research
Peptide B
BPC-157
verifiedBioGate · GREENGrade B
soft-tissue recovery
Identity
- Sequence≠
YLRIVQCRSVEGSCGFGEPPPGKPADDAGLV - Length≠16 aa15 aa
- Molecular weight≠1815.131419.55
- Modifications≠disulfide C7-C15tyrosine-extended hGH C-terminal fragmentacetyl-N-terminus
- Mechanism
Modified C-terminal fragment of hGH (residues 176-191); preclinically lipolytic but failed to demonstrate clinical weight loss in Phase 2 trials.
Pentadecapeptide derived from human gastric juice; modulates VEGF and growth-hormone receptor expression in injured tissue.
Provenance
- BioGate≠warningBioGate · AMBERverifiedBioGate · GREEN
- PDA-V1 outer≠
- Inputs hash≠
- Model versionstructure-fm-2026.04structure-fm-2026.04
- PDA candidates≠54
Outcomes
- RWE cohorts≠65
- Total participants≠459270
- Primary endpoint Δ≠+1.09 Δ HRV ms (8-week)95% CI [0.64, 1.54]-1.7 Δ HRV ms (8-week)95% CI [-2.46, -0.94]
- LOO posterior≠68.7%β(51.8, 23.6)88.1%β(33.8, 4.6)
- Top-grade citations≠Grade C0 of 1Grade B2 of 2
Economics
- IPNFT≠unmintedMolecule IPNFT V2Solana · 73 holders
- Royalty cascade≠-10.04%
Indications
- Listed indications≠
- · lipolysis research
- · obesity (negative Phase 2 outcome)
- · soft-tissue recovery
- · GI mucosal repair
- · tendon healing